Interactions between immune and malignant cells have been known to have clinical
relevance for decades. The potential for immune control is now being therapeutically …

Ageing is correlated with elevated bladder cancer incidence, morbidity and mortality.
Advanced age is also associated with elevated markers of chronic inflammation and …

CD68 is a heavily glycosylated glycoprotein that is highly expressed in macrophages and
other mononuclear phagocytes. Traditionally, CD68 is exploited as a valuable cytochemical …

In recent years, it has been established that programmed cell death protein ligand 1 (PD-L1)–
mediated inhibition of activated PD-1+ T lymphocytes plays a major role in tumor escape …

Bladder cancer is an important public health concern owing to its prevalence, high
recurrence risk and treatment failures. Maintaining the equilibrium between prompt and …

With the increased prevalence of antibiotic-resistant bacteria infections, there is a pressed
need for innovative antimicrobial agent. Here, we report a benign ε-polylysine/silver …

Immunosurveillance, which describes the immunologically mediated elimination of
transformed cells, has been widely accepted in the context of bladder cancer for many …

Pparg, a nuclear receptor, is downregulated in basal subtype bladder cancers that tend to
be muscle invasive and amplified in luminal subtype bladder cancers that tend to be non …

Objective Differences in gastric cancer (GC) clinical outcomes between patients in Asian
and non-Asian countries has been historically attributed to variability in clinical …

The outcome of tumors results from genetic and epigenetic modifications of the transformed
cells and also from the interactions of the malignant cells with their tumor microenvironment …